Haemophilus Influenzae (Hib) Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Condition: Haemophilus Influenzae Type bInterventions: Biological: GSK Biologicals' Haemophilus influenzae type b vaccine (GSK 208108); Biological: ActHIB™; Biological: Pentacel™; Biological: Pediarix™; Biological: Prevnar 13™; Biological: Rotarix™; Biological: Engerix™-B; Biological: Infanrix™Sponsor: GlaxoSmithKlineCompleted - verified April 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 22, 2009 Category: Research Source Type: clinical trials

Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Condition: Haemophilus Influenzae Type bInterventions: Biological: GSK Biologicals' Haemophilus influenzae type b vaccine (GSK 208108); Biological: ActHIB™; Biological: Pentacel™; Biological: Pediarix™; Biological: Prevnar 13™; Biological: Rotarix™; Biological: Engerix™-B; Biological: Infanrix™Sponsor: GlaxoSmithKlineCompleted - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 22, 2009 Category: Research Source Type: clinical trials

Surveillance Program to Determine Product Specific Rates of Invasive Hib Disease
Conditions: Haemophilus Infections; Diphtheria; Tetanus; Polio; PertussisIntervention: Biological: DTaP-IPV/HibSponsor: Sanofi Pasteur, a Sanofi CompanyActive, not recruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 3, 2009 Category: Research Source Type: clinical trials

Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered With or Without Routine Infant Vaccinations to Healthy Infants According to Different Immunization Schedules
Condition: Meningococcal InfectionsInterventions: Biological: rMenB+OMV NZ; Biological: combined diphtheria,tetanus,pertussis+polio+Hepatitis B+Haemophilus influenzae B vaccine; Biological: Pneumococcal vaccineSponsor: Novartis VaccinesCompleted - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 22, 2008 Category: Research Source Type: clinical trials

Study of Modified Process Hib/Hep B Vaccine in Infants (V121-019)(COMPLETED)
Conditions: Haemophilus Influenzae Type B; Hepatitis BInterventions: Biological: Comparator: Modified Process Vaccine; Biological: Comparator: COMVAX™Sponsor: Merck Sharp & Dohme Corp.Completed - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2007 Category: Research Source Type: clinical trials

Study of Modified Process Hib/Hep B Vaccine in Infants (V121-019)(COMPLETED)
Conditions: Haemophilus Influenzae Type B; Hepatitis BInterventions: Biological: Comparator: Modified Process Vaccine; Biological: Comparator: COMVAX™Sponsor: Merck Sharp & Dohme Corp.Completed - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2007 Category: Research Source Type: clinical trials

Study to Compare Pediacel® to Infanrix®-IPV+Hib When Both Are Co-Administered With Prevenar® in Infants and Toddlers
Conditions: Diphtheria; Tetanus; Pertussis; Poliomyelitis; Haemophilus Influenzae Type bInterventions: Biological: PEDIACEL® and Prevenar®; Biological: Infanrix®-IPV+Hib and Prevenar®Sponsor: Sanofi Pasteur, a Sanofi CompanyCompleted - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 21, 2006 Category: Research Source Type: clinical trials